News from NORD

CORD Offers Consensus Framework for Ethical Collaboration

Publish date: February 17, 2017

 

The Canadian Organization for Rare Disorders (CORD) has developed a Consensus Framework to encourage ethical collaboration among patient organizations, health care professionals, and the pharmaceutical industry.

Recommended Reading

Adolescents, boys, black children most likely to be hospitalized in SJS and TEN
MDedge Pediatrics
AWaRDS Study Examines Services for Adults With Rare Disorders
MDedge Pediatrics
West Nile virus accounted for 95% of domestic arboviral disease in 2015
MDedge Pediatrics
VIDEO: Public reporting of congenital heart disease outcomes should be easily understood
MDedge Pediatrics
Nicardipine okay to use after pediatric cardiac surgery
MDedge Pediatrics
FDA approves Emflaza for Duchenne muscular dystrophy
MDedge Pediatrics
NORD Seeks Input Regarding Patient Protections and ACA
MDedge Pediatrics
Rare Disease Day 2017 Will Highlight Research Theme
MDedge Pediatrics
NORD to Partner Again With Hole in the Wall Gang Camp
MDedge Pediatrics
Apply Now to Join NORD’s Charity Marathon Team
MDedge Pediatrics